Insider Trades30 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Buy | LIVN | Ahmet Tezel | Chief Innovation Officer | 16,795 | $58.81 | $4.3B | -8.84% | +60.14% | $987.7K | +22.76% | — | Sell Now |
| Jun 15, 2026 | Sell | LIVN | Ahmet Tezel | Chief Innovation Officer | 1,032 | $79.70 | $4.3B | -8.84% | +60.14% | $82.3K | -7.91% | — | Sell Now |
| Mar 30, 2026 | Sell | LIVN | Ahmet Tezel | Chief Innovation Officer | 1,186 | $61.27 | $4.3B | -8.84% | +60.14% | $72.7K | -2.97% | — | Sell Now |
| Mar 30, 2026 | Sell | LIVN | Franco Poletti | President, Cardiopulmonary | 1,370 | $61.27 | $4.3B | -8.84% | +60.14% | $83.9K | -7.69% | — | Sell Now |
| Mar 30, 2026 | Sell | LIVN | Natalia Kozmina | Chief Human Resources Officer | 1,374 | $61.27 | $4.3B | -8.84% | +60.14% | $84.2K | -3.55% | — | Sell Now |
| Mar 30, 2026 | Sell | LIVN | Stephanie Bolton | President, Global Epilepsy | 8,377 | $61.27 | $4.3B | -8.84% | +60.14% | $513.3K | -14.70% | — | Sell Now |
| Mar 30, 2026 | Sell | LIVN | Vladimir Makatsaria | Chief Executive Officer | 11,159 | $61.27 | $4.3B | -8.84% | +60.14% | $683.7K | -6.49% | — | Sell Now |
| Mar 30, 2026 | Sell | LIVN | Alex Shvartsburg | Chief Financial Officer | 12,868 | $61.27 | $4.3B | -8.84% | +60.14% | $788.4K | -12.45% | — | Sell Now |
| Mar 11, 2026 | Buy | LIVN | Franco Poletti | President, Cardiopulmonary | 4,189 | $59.88 | $4.3B | -8.84% | +60.14% | $250.8K | +0.32% | — | Sell Now |
| Dec 15, 2025 | Sell | LIVN | Franco Poletti | President, Cardiopulmonary | 416 | $63.06 | $4.3B | -8.84% | +60.14% | $26.2K | -4.49% | — | Sell Now |
| Dec 15, 2025 | Sell | LIVN | Michael Damon Hutchinson | SVP, CLO and Company Secretary | 1,122 | $63.06 | $4.3B | -8.84% | +60.14% | $70.8K | -11.03% | — | Sell Now |
| Sep 15, 2025 | Sell | LIVN | Franco Poletti | President, Cardiopulmonary | 277 | $55.43 | $4.3B | -8.84% | +60.14% | $15.4K | -2.64% | — | Sell Now |
| Jun 15, 2025 | Sell | LIVN | Ahmet Tezel | Chief Innovation Officer | 1,032 | $45.76 | $4.3B | -8.84% | +60.14% | $47.2K | -8.70% | — | Sell Now |
| Mar 30, 2025 | Sell | LIVN | Franco Poletti | President, Cardiopulmonary | 542 | $39.13 | $4.3B | -8.84% | +60.14% | $21.2K | -1.23% | — | Sell Now |
| Mar 30, 2025 | Sell | LIVN | Michael Damon Hutchinson | Chief Legal Officer | 1,020 | $39.13 | $4.3B | -8.84% | +60.14% | $39.9K | -1.69% | — | Sell Now |
| Mar 30, 2025 | Sell | LIVN | Stephanie Bolton | President, Global Epilepsy | 2,835 | $39.13 | $4.3B | -8.84% | +60.14% | $110.9K | -4.82% | — | Sell Now |
| Mar 30, 2025 | Sell | LIVN | Alex Shvartsburg | Chief Financial Officer | 3,516 | $39.13 | $4.3B | -8.84% | +60.14% | $137.6K | -3.60% | — | Sell Now |
| Mar 30, 2025 | Sell | LIVN | Vladimir Makatsaria | Chief Executive Officer | 5,046 | $39.13 | $4.3B | -8.84% | +60.14% | $197.4K | -2.30% | — | Sell Now |
| Dec 15, 2024 | Sell | LIVN | Alex Shvartsburg | Chief Financial Officer | 229 | $51.50 | $4.3B | -8.84% | +60.14% | $11.8K | -1.18% | — | Sell Now |
| Dec 15, 2024 | Sell | LIVN | Franco Poletti | President, Cardiopulmonary | 416 | $51.50 | $4.3B | -8.84% | +60.14% | $21.4K | -4.84% | — | Sell Now |
| Dec 15, 2024 | Sell | LIVN | Michael Damon Hutchinson | Chief Legal Officer | 784 | $51.50 | $4.3B | -8.84% | +60.14% | $40.4K | -8.67% | — | Sell Now |
| Jun 15, 2024 | Sell | LIVN | Alex Shvartsburg | CFO | 670 | $52.68 | $4.3B | -8.84% | +60.14% | $35.3K | -3.45% | — | Sell Now |
| Mar 30, 2024 | Sell | LIVN | Michael Damon Hutchinson | Chief Legal Officer | 542 | $55.94 | $4.3B | -8.84% | +60.14% | $30.3K | -1.45% | — | Sell Now |
| Mar 30, 2024 | Sell | LIVN | Stephanie Bolton | President, Global Epilepsy | 3,643 | $55.94 | $4.3B | -8.84% | +60.14% | $203.8K | -8.28% | — | Sell Now |
| Mar 30, 2024 | Sell | LIVN | Trui Hebbelinck | Chief Human Resources Officer | 5,541 | $55.94 | $4.3B | -8.84% | +60.14% | $310.0K | -11.99% | — | Sell Now |
| Mar 30, 2024 | Sell | LIVN | Alex Shvartsburg | CFO | 6,310 | $55.94 | $4.3B | -8.84% | +60.14% | $353.0K | -8.89% | — | Sell Now |
| Feb 29, 2024 | Sell | LIVN | William A Kozy | Chairman and CEO | 4,871 | $54.81 | $4.3B | -8.84% | +60.14% | $267.0K | -15.07% | — | Sell Now |
| Dec 15, 2023 | Sell | LIVN | Alex Shvartsburg | CFO | 167 | $50.07 | $4.3B | -8.84% | +60.14% | $8.4K | -1.64% | — | Sell Now |
| Dec 15, 2023 | Sell | LIVN | Michael Damon Hutchinson | Chief Legal Officer | 904 | $50.07 | $4.3B | -8.84% | +60.14% | $45.3K | -10.03% | — | Sell Now |
| Sep 15, 2023 | Sell | LIVN | Trui Hebbelinck | Chief Human Resources Officer | 207 | $56.80 | $4.3B | -8.84% | +60.14% | $11.8K | -2.67% | — | Sell Now |